Millipore Sigma Vibrant Logo

GR11 Anti-IGF-IR (Ab-1) Mouse mAb (αIR3)

This Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) is validated for use in Immunoblotting, IF, IP, Neutralization Studies, Paraffin Sections for the detection of IGF-IR (Ab-1).

Anti-IGF-IR (Ab-1) Mouse mAb (αIR3): のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Anti-IGF-R, Anti-Insulin-Like Growth Factor Receptor

View This Product on Sigma-Aldrich
GR11
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
GR11-100UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 100 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewRecognizes the ~130 kDa α and the ~90 kDa β subunits of IGF-I receptor.
      Catalogue NumberGR11
      Brand Family Calbiochem®
      SynonymsAnti-IGF-R, Anti-Insulin-Like Growth Factor Receptor
      References
      ReferencesRoth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M., 1987. Science 257, 1452.
      Rechler, M.M. and Nissley, S.P., 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S. and Froesch, E.R., 1986. Hormone Res. 24, 121.
      Humbel, R.E., 1984. I. Chemistry; in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York).
      Kull, F.C., et al. 1983. J. Biol. Chem. 258, 6561.
      Product Information
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Negative controlHS27 cells
      Positive controlHepG2 cells
      Preservative≤0.1% sodium azide
      Quality LevelMQ100
      Applications
      Key Applications Immunofluorescence
      Immunoprecipitation
      Not Western Blot
      Not Paraffin Sections
      Application NotesImmunoblotting (not recommended)
      Immunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1-2 µg/sample)
      Neutralization Studies (1 µg/ml; use Cat. No. GR11L)
      Paraffin Sections (not recommended)
      Application CommentsAnti-IGF-I Receptor (Ab-1) Mouse mAb (αIR3) immunoprecipitates the α and β subunits of the IGF-I receptor. Blocks IGF-I binding to its receptor and may bind weakly to the insulin receptor. It also inhibits the growth of MCF-7 cells in culture suggesting the IGF-I receptor may be involved in autocrine regulation of cell growth (see application references). Antibody should be titrated for optimal results in indvidual systems.
      Biological Information
      Immunogenpartially purified, human placenta IGF-I receptor
      ImmunogenHuman
      CloneαIR3
      HostMouse
      IsotypeIgG₁
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Yes
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      GR11-100UGCN 04055977228229

      Documentation

      Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) 試験成績書（CoA）

      タイトルロット番号
      GR11

      参考資料

      参考資料の概要
      Roth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M., 1987. Science 257, 1452.
      Rechler, M.M. and Nissley, S.P., 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S. and Froesch, E.R., 1986. Hormone Res. 24, 121.
      Humbel, R.E., 1984. I. Chemistry; in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York).
      Kull, F.C., et al. 1983. J. Biol. Chem. 258, 6561.

      引用

      Title
    • Rita Nahta, et al. (2005) Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Research 65, 11118-11128.
    • Daniel E. Syroid, et al. (1999) A role for insulin-like growth factor-I in the regulation of Schwann cell survival. Journal of Neuroscience 19, 2059-2068.
    • Donald M. Henricks, et al. (1998) Identification of insulin-like growth factor I in bovine seminal plasma and its receptor on spermatozoa: influence on sperm motility. Biology of Reproduction 59, 330-337.
      		•
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision24-August-2007 RFH
      SynonymsAnti-IGF-R, Anti-Insulin-Like Growth Factor Receptor
      ApplicationImmunoblotting (not recommended)
      Immunofluorescence (1-5 µg/ml)
      Immunoprecipitation (1-2 µg/sample)
      Neutralization Studies (1 µg/ml; use Cat. No. GR11L)
      Paraffin Sections (not recommended)
      DescriptionPurified mouse monoclonal antibody generated by immunizing SJL mice with the specified immunogen and fusing splenocytes with FO mouse myeloma cells (see application references). Recognizes the ~130 kDa α and the ~90 kDa β subunits of IGF-I receptor.
      BackgroundThe insulin-like growth factors (IGFs) or somatomedins are mitogenic peptides present in the plasma of human, rat, and other species. Two distinct but chemically related IGFs have been purified from human plasma: IGF-I (Somatomedin C) and IGF-II. They are single chain polypeptides with molecular weights of 7,640 and 7,471, respectively. Types I and II IGF receptors differ in their structure and in their peptide binding specificity. Type I IGF receptors are structurally homologous to insulin receptors and contain α-subunits (Mr=130,000) that bind peptide, and β-subunits (Mr=90,000), which have intrinsic tyrosine kinase activity. The protein-tyrosine kinase activity of the insulin receptor and, presumably the IGF-I receptor, is required for insulin to stimulate all of its biological responses in cells. Type II receptors are a single polypeptide (Mr=260,000), lack protein-tyrosine kinase activity, and have been shown to be identical to the mannose-6-phosphate receptor.
      HostMouse
      Immunogen speciesHuman
      Immunogenpartially purified, human placenta IGF-I receptor
      CloneαIR3
      IsotypeIgG₁
      Specieshuman
      Positive controlHepG2 cells
      Negative controlHS27 cells
      FormLiquid
      FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
      Concentration Label Please refer to vial label for lot-specific concentration
      Preservative≤0.1% sodium azide
      CommentsAnti-IGF-I Receptor (Ab-1) Mouse mAb (αIR3) immunoprecipitates the α and β subunits of the IGF-I receptor. Blocks IGF-I binding to its receptor and may bind weakly to the insulin receptor. It also inhibits the growth of MCF-7 cells in culture suggesting the IGF-I receptor may be involved in autocrine regulation of cell growth (see application references). Antibody should be titrated for optimal results in indvidual systems.
      Storage +2°C to +8°C
      Do Not Freeze Yes
      Toxicity Standard Handling
      ReferencesRoth, R. 1988. Science 239, 1269.
      Rohlik, Q.T., et al. 1987. Biochem. Biophy Res. Comm. 149, 276.
      Rosen, O.M., 1987. Science 257, 1452.
      Rechler, M.M. and Nissley, S.P., 1986. Hormone Res. 24, 152.
      Ullrich, A., et al. 1986. EMBO J. 5, 2503.
      Zapf, S. and Froesch, E.R., 1986. Hormone Res. 24, 121.
      Humbel, R.E., 1984. I. Chemistry; in Li Hormonal proteins and peptides. Vol 12, Chap. 4 (Academic Press, New York).
      Kull, F.C., et al. 1983. J. Biol. Chem. 258, 6561.
      Citation
    • Rita Nahta, et al. (2005) Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Research 65, 11118-11128.
    • Daniel E. Syroid, et al. (1999) A role for insulin-like growth factor-I in the regulation of Schwann cell survival. Journal of Neuroscience 19, 2059-2068.
    • Donald M. Henricks, et al. (1998) Identification of insulin-like growth factor I in bovine seminal plasma and its receptor on spermatozoa: influence on sperm motility. Biology of Reproduction 59, 330-337.
      		•

      関連製品＆アプリケーション

      Related Products

      カタログ番号 説明  
      GR11L Anti-IGF-IR (Ab-1) Mouse mAb (αIR3) 価格＆在庫状況を表示

      カテゴリー

      Life Science Research > Antibodies and Assays > Primary Antibodies